Cutia Therapeutics CEO Increase Shareholding in Company

Like
Comment
Favorite

Cutia Therapeutics CEO Increase Shareholding in Company

MT Newswires Live2024-11-11

Cutia Therapeutics (HKG:2487) said its chief executive officer, Zhang Lele, purchased 5,000 shares of the company through the open market for HK$49,280, according to a Monday filing with the Hong Kong bourse.

Zhang also bought 28,000 shares of the company in October for HK$343,932 and has not ruled out the possibility of further purchases.

These aggregate purchases of shares stood at 33,000 shares for a total of HK$393,212, with an average price of about HK$11.916 per share.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

No comments yet

抱歉，当前请求异常(-1)

7x24

All

23:12
Australia's S&P/ASX 200 Index Rises 0.6% to 7,980.40 Points in Early Trade
23:06
LG Energy Solution: to Supply ESS to Poland's Pge of About 16 Gigawatts From 2026
23:04
Mindax - Raised a$7.2 Mln at Issue Price a$0.05 per Share
22:58
Li-S Energy Ltd - Collaboration With Kea Aerospace to Power High Altitude Uavs
22:56
Eurogroup Laminations Spa - Consolidated Revenues for 2024 Amounted to EUR 869.4 Mln

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2482211284?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2024-11-11 08:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2482211284","market":"us","top_or_hot":-1,"title":"Cutia Therapeutics CEO Increase Shareholding in Company","media":"MT Newswires Live","content":"<html><body><p> Cutia <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (HKG:2487) said its chief executive officer, Zhang Lele, purchased 5,000 shares of the company through the open market for HK$49,280, according to a Monday filing with the Hong Kong bourse.</p><p>Zhang also bought 28,000 shares of the company in October for HK$343,932 and has not ruled out the possibility of further purchases.</p><p>These aggregate purchases of shares stood at 33,000 shares for a total of HK$393,212, with an average price of about HK$11.916 per share.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cutia Therapeutics CEO Increase Shareholding in Company</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCutia Therapeutics CEO Increase Shareholding in Company\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2024-11-11 08:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Cutia <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (HKG:2487) said its chief executive officer, Zhang Lele, purchased 5,000 shares of the company through the open market for HK$49,280, according to a Monday filing with the Hong Kong bourse.</p><p>Zhang also bought 28,000 shares of the company in October for HK$343,932 and has not ruled out the possibility of further purchases.</p><p>These aggregate purchases of shares stood at 33,000 shares for a total of HK$393,212, with an average price of about HK$11.916 per share.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LENZ","symbol_name":"Therapeutics","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2482211284","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2482211284","pubTimestamp":1731285939,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Cutia Therapeutics  said its chief executive officer, Zhang Lele, purchased 5,000 shares of the company through the open market for HK$49,280, according to a Monday filing with the Hong Kong bourse.Zhang also bought 28,000 shares of the company in October for HK$343,932 and has not ruled out the possibility of further purchases.These aggregate purchases of shares stood at 33,000 shares for a total of HK$393,212, with an average price of about HK$11.916 per share.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LENZ":"Therapeutics","BK1161":"生物科技","02487":"科笛-B","BK4139":"生物科技"},"translate_title":"Cutia Therapeutics首席执行官增持公司股份","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02487":0.9,"LENZ":1},"content_text":"Cutia Therapeutics (HKG:2487) said its chief executive officer, Zhang Lele, purchased 5,000 shares of the company through the open market for HK$49,280, according to a Monday filing with the Hong Kong bourse.Zhang also bought 28,000 shares of the company in October for HK$343,932 and has not ruled out the possibility of further purchases.These aggregate purchases of shares stood at 33,000 shares for a total of HK$393,212, with an average price of about HK$11.916 per share.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}